Liu, Y.;                     Güler, R.;                     Liao, Y.;                     Vorobyeva, A.;                     Widmark, O.;                     Meuleman, T.J.;                     Koijen, A.;                     van den Bos, L.J.;                     Naasz, R.;                     Bodenko, V.;     
    et al.    Biologic Evaluation of a Heterodimeric HER2-Albumin Targeted Affibody Molecule Produced by Chemo-Enzymatic Peptide Synthesis. Pharmaceutics 2022, 14, 2519.
    https://doi.org/10.3390/pharmaceutics14112519
    AMA Style
    
                                Liu Y,                                 Güler R,                                 Liao Y,                                 Vorobyeva A,                                 Widmark O,                                 Meuleman TJ,                                 Koijen A,                                 van den Bos LJ,                                 Naasz R,                                 Bodenko V,         
        et al.        Biologic Evaluation of a Heterodimeric HER2-Albumin Targeted Affibody Molecule Produced by Chemo-Enzymatic Peptide Synthesis. Pharmaceutics. 2022; 14(11):2519.
        https://doi.org/10.3390/pharmaceutics14112519
    
    Chicago/Turabian Style
    
                                Liu, Yongsheng,                                 Rezan Güler,                                 Yunqi Liao,                                 Anzhelika Vorobyeva,                                 Olof Widmark,                                 Theodorus J. Meuleman,                                 Anna Koijen,                                 Leendert J. van den Bos,                                 Robert Naasz,                                 Vitalina Bodenko,         
         and et al.        2022. "Biologic Evaluation of a Heterodimeric HER2-Albumin Targeted Affibody Molecule Produced by Chemo-Enzymatic Peptide Synthesis" Pharmaceutics 14, no. 11: 2519.
        https://doi.org/10.3390/pharmaceutics14112519
    
    APA Style
    
                                Liu, Y.,                                 Güler, R.,                                 Liao, Y.,                                 Vorobyeva, A.,                                 Widmark, O.,                                 Meuleman, T. J.,                                 Koijen, A.,                                 van den Bos, L. J.,                                 Naasz, R.,                                 Bodenko, V.,                                 Orlova, A.,                                 Ekblad, C.,                                 Tolmachev, V.,                                 & Frejd, F. Y.        
        
        (2022). Biologic Evaluation of a Heterodimeric HER2-Albumin Targeted Affibody Molecule Produced by Chemo-Enzymatic Peptide Synthesis. Pharmaceutics, 14(11), 2519.
        https://doi.org/10.3390/pharmaceutics14112519